Savient Pharmaceuticals, Inc. Files for Chapter 11, Seeks to Sell Assets for About $55 Million

Published: Oct 15, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

U.S. biotech firm Savient Pharmaceuticals Inc filed for Chapter 11 bankruptcy protection in a Delaware court on Monday and said it has agreed to sell most of its assets to Sloan Holdings CV for about $55 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news